Skip to main content

Official Journal of the Human Genome Organisation

Figure 2 | The HUGO Journal

Figure 2

From: Translational genomics in personalized medicine – scientific challenges en route to clinical practice

Figure 2

More than 1/3 of all clinical studies in oncology include biomarkers. The graphic illustrates the involvement of biomarkers in clinical studies, sorted by therapeutic area, with more than 1/3 of all clinical studies in oncology involving biomarkers (http://www.clinicaltrials.gov, 30.000 studies from 1970 until February 2011, The Boston Consulting Group analysis).

Back to article page